Cargando…
Is there a clinical usefulness for radiolabeled somatostatin analogues beyond the consolidated role in NETs?
The somatostatin (SS) receptor scintigraphy (SRS), using octreotide radiolabelled with (111)In (Ocreoscan©, OCT), is a consolidated diagnostic procedure in patients with neuroendocrine tumors (NET) because of an increased expression of somatostatin receptors (SS-R) on neoplastic cells. Uptake of SS...
Autores principales: | Cuccurullo, Vincenzo, Di Stasio, Giuseppe Danilo, Prisco, Maria Rosaria, Mansi, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761181/ https://www.ncbi.nlm.nih.gov/pubmed/29379249 http://dx.doi.org/10.4103/ijri.IJRI_431_16 |
Ejemplares similares
-
Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors
por: Ambrosini, Valentina, et al.
Publicado: (2022) -
Nuclear Medicine in Prostate Cancer: A New Era for Radiotracers
por: Cuccurullo, Vincenzo, et al.
Publicado: (2018) -
SPECT/CT with radiolabeled somatostatin analogues in the evaluation
of systemic granulomatous infections
por: Monteiro, Paulo Henrique Silva, et al.
Publicado: (2017) -
From the Magic Bullet to Theragnostics: Certitudes and Hypotheses, Trying to Optimize the Somatostatin Model
por: Di Stasio, Giuseppe Danilo, et al.
Publicado: (2021) -
Radiolabeled Somatostatin Analogs—A Continuously Evolving Class of Radiopharmaceuticals
por: Fani, Melpomeni, et al.
Publicado: (2022)